The baby formula shortage likely won't end until July, FDA Commissioner Robert Califf said Tuesday.
Driving the news: “My expectation is that within two months we should be beyond normal, and with a plethora,” Califf said at a Senate Health Committee hearing Thursday, per CNBC.
The growing monkeypox outbreak may appear alarming to people — potentially triggering bad memories of the rapid spread of COVID over the globe — but it does not contain the same threat level as a pandemic, experts tell Axios.
The big picture: How monkeypox is spreading around the world — with nine U.S. cases confirmed so far — is "new and certainly concerning" but the virus isn't behaving completely unexpectedly, says the CDC's poxvirus epidemiology team lead, Andrea McCollum.
More than half of the country's 15 largest cities saw population decreases during the coronavirus pandemic, according to new U.S. census data released Thursday measuring city growth from July 2020 to July 2021.
Driving the news: The switch to remote work during the pandemic enabled many people to move, prompted desires for cheaper cost of living or lifestyle changes.
Pharmacists and drug wholesalers can import prescription medicines from Canada for up to two years as part of state programs aimed at bringing down drug costs, according to final FDA guidance released Thursday.
Why it matters: With President Biden's drug pricing agenda still stalled, the FDA is further clarifying how states could take advantage of lower drug costs abroad without the need to limit prices in the U.S.
The Supreme Court is likely to clear the way for new anti-abortion laws in just a few months — but red states aren't waiting.
The big picture: Conservative legislatures are passing a raft of controversial new laws, many of which push the envelope further than the courts have ever allowed. But with the court poised to significantly weaken Roe v. Wade, if not overturn it altogether, red states appear confident that these new measures will stand.
The first federally backed "test to treat" site is slated to open in Rhode Island on Thursday, an initiative aimed at expanding access to COVID-19 anti-viral pills as virus cases are rising across the country.
Why it matters: The pills dramatically reduce the chances that someone with COVID will become severely ill, making the medication a key tool for living with the virus, writes Axios' Caitlin Owens.
An ongoing surge of reported COVID cases in the Northeast showed signs of easing even as cases continued to jump around the rest of the country.
Why it matters: While this data likely understates the actual number of cases, it's an indicator of a "hidden wave" of cases burning through social circles across the U.S. right now even as America fights to get back to normalcy.
It comes as anecdotal reports of COVID among groups of friends, and a slew of confirmed cases of high-profile individuals, most recently Wyoming Rep. Liz Cheney and Washington Gov. Jay Inslee.
A renewed focus on health and wellness has been a boon to the reputations of health care companies, according to new rankings from the annual Axios Harris Poll 100.
The big picture: Health care brands helped Americans get through the COVID pandemic, improving their level of confidence and trust with consumers in the process.
Firearms were the leading cause of death for kids one and older for the first time in 2020, the most recent year for which CDC data is available.
Why it matters: The firearm death rate among children is steadily rising, as more kids are involved in gun-related homicides like Tuesday's mass shooting in Uvalde, Texas,as well as suicides and accidents.
